Market capitalization | $12.93b |
Enterprise Value | $20.35b |
P/E (TTM) P/E ratio | 27.10 |
EV/FCF (TTM) EV/FCF | 25.28 |
EV/Sales (TTM) EV/Sales | 2.47 |
P/S ratio (TTM) P/S ratio | 1.57 |
P/B ratio (TTM) P/B ratio | 4.36 |
Revenue growth (TTM) Revenue growth | 0.68% |
Revenue (TTM) Revenue | $8.25b |
As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.
11 Analysts have issued a Solventum forecast:
11 Analysts have issued a Solventum forecast:
Dec '24 |
+/-
%
|
||
Revenue | 8,253 8,253 |
1%
1%
|
|
Gross Profit | 4,640 4,640 |
1%
1%
|
|
EBITDA | 1,636 1,636 |
27%
27%
|
EBIT (Operating Income) EBIT | 1,083 1,083 |
36%
36%
|
Net Profit | 478 478 |
64%
64%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.
Head office | United States |
CEO | Bryan Hanson |
Employees | 22,000 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.